Ildong Pharmaceutical Co., Ltd. (249420.KS)
KRW 11350.0
(-5.42%)
KRW 11350.0
(-5.42%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 84.62 Billion KRW | -13.87% |
| 2022 | 98.24 Billion KRW | 18.96% |
| 2021 | 82.58 Billion KRW | -7.44% |
| 2020 | 89.22 Billion KRW | 27.93% |
| 2019 | 69.74 Billion KRW | 31.1% |
| 2018 | 53.2 Billion KRW | -11.31% |
| 2017 | 59.98 Billion KRW | -1.99% |
| 2016 | 61.2 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 85.82 Billion KRW | 1.42% |
| 2024 Q2 | 93.67 Billion KRW | 9.14% |
| 2023 Q4 | 84.62 Billion KRW | -5.68% |
| 2023 FY | 84.62 Billion KRW | -13.87% |
| 2023 Q2 | 108.08 Billion KRW | 1.51% |
| 2023 Q1 | 106.47 Billion KRW | 8.37% |
| 2023 Q3 | 89.71 Billion KRW | -16.99% |
| 2022 Q1 | 97.1 Billion KRW | 17.58% |
| 2022 Q4 | 98.24 Billion KRW | -1.45% |
| 2022 Q3 | 99.69 Billion KRW | -4.15% |
| 2022 Q2 | 104.01 Billion KRW | 7.11% |
| 2022 FY | 98.24 Billion KRW | 18.96% |
| 2021 Q2 | 92.15 Billion KRW | 3.21% |
| 2021 Q3 | 87.28 Billion KRW | -5.29% |
| 2021 Q4 | 82.58 Billion KRW | -5.38% |
| 2021 FY | 82.58 Billion KRW | -7.44% |
| 2021 Q1 | 89.28 Billion KRW | 0.07% |
| 2020 Q1 | 74.76 Billion KRW | 7.2% |
| 2020 Q2 | 84.83 Billion KRW | 13.46% |
| 2020 FY | 89.22 Billion KRW | 27.93% |
| 2020 Q4 | 89.22 Billion KRW | -1.75% |
| 2020 Q3 | 90.81 Billion KRW | 7.05% |
| 2019 Q4 | 69.74 Billion KRW | -5.88% |
| 2019 Q3 | 74.09 Billion KRW | 5.22% |
| 2019 Q2 | 70.42 Billion KRW | 18.0% |
| 2019 Q1 | 59.68 Billion KRW | 12.18% |
| 2019 FY | 69.74 Billion KRW | 31.1% |
| 2018 Q2 | 62.57 Billion KRW | -3.27% |
| 2018 Q4 | 53.2 Billion KRW | -5.4% |
| 2018 Q1 | 64.69 Billion KRW | 7.85% |
| 2018 Q3 | 56.23 Billion KRW | -10.13% |
| 2018 FY | 53.2 Billion KRW | -11.31% |
| 2017 Q3 | 59.52 Billion KRW | -4.57% |
| 2017 Q1 | 59.51 Billion KRW | -2.76% |
| 2017 FY | 59.98 Billion KRW | -1.99% |
| 2017 Q2 | 62.36 Billion KRW | 4.8% |
| 2017 Q4 | 59.98 Billion KRW | 0.78% |
| 2016 FY | 61.2 Billion KRW | 0.0% |
| 2016 Q4 | 61.2 Billion KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -91.663% |
| Dong-A Socio Holdings Co., Ltd. | 117.85 Billion KRW | 28.195% |
| Ildong Holdings Co., Ltd. | 91.16 Billion KRW | 7.177% |
| HANDOK Inc. | 94.46 Billion KRW | 10.418% |
| Kukje Pharma Co., Ltd. | 21.24 Billion KRW | -298.357% |
| Yuhan Corporation | 284.75 Billion KRW | 70.282% |
| Dong-A ST Co., Ltd. | 116.31 Billion KRW | 27.245% |
| SAMSUNG PHARM. Co., LTD. | 16.25 Billion KRW | -420.482% |
| Hanmi Pharm. Co., Ltd. | 288.81 Billion KRW | 70.7% |
| Hanall Biopharma Co.,Ltd | 32.38 Billion KRW | -161.311% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | -37.098% |
| Dong Sung Bio Pharm.Co.,Ltd. | 19.47 Billion KRW | -334.478% |
| MYUNGMOON Pharm co.,Ltd | 30.28 Billion KRW | -179.468% |
| Hana Pharm Co., Ltd. | 48.34 Billion KRW | -75.032% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -91.663% |
| Ilsung Pharmaceuticals Co., Ltd. | 31.24 Billion KRW | -170.875% |
| REYON Pharmaceutical Co., Ltd. | 35.17 Billion KRW | -140.569% |
| Aprogen pharmaceuticals,Inc. | 48.12 Billion KRW | -75.829% |
| JW Holdings Corporation | 147.58 Billion KRW | 42.663% |
| Chong Kun Dang Pharmaceutical Corp. | 261.43 Billion KRW | 67.631% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | 20.235% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | -56.933% |
| Hyundai Pharmaceutical Co., Ltd. | 26.99 Billion KRW | -213.444% |
| Samil Pharmaceutical Co.,Ltd | 32.51 Billion KRW | -160.289% |
| Jeil Pharmaceutical Co.,Ltd | 109.76 Billion KRW | 22.907% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -91.663% |
| Kwang Dong Pharmaceutical Co., Ltd. | 188.64 Billion KRW | 55.141% |
| Daewoong pharmaceutical Co.,Ltd | 241.54 Billion KRW | 64.966% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | 20.235% |
| Yuhan Corporation | 284.75 Billion KRW | 70.282% |
| Jeil Pharma Holdings Inc | 125.28 Billion KRW | 32.453% |
| Yungjin Pharm. Co., Ltd. | 61.98 Billion KRW | -36.519% |
| Suheung Co., Ltd. | 259.84 Billion KRW | 67.433% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | 20.235% |
| Samjin Pharmaceuticals Co., Ltd. | 79.6 Billion KRW | -6.307% |
| Korea United Pharm Inc. | 49.14 Billion KRW | -72.202% |
| CKD Bio Corp. | 69.08 Billion KRW | -22.497% |
| Daewon Pharmaceutical Co., Ltd. | 105.07 Billion KRW | 19.466% |
| Dongwha Pharm.Co.,Ltd | 70.69 Billion KRW | -19.699% |
| Whan In Pharm Co.,Ltd. | 54.05 Billion KRW | -56.542% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | -56.933% |
| Chong Kun Dang Holdings Corp. | 194.76 Billion KRW | 56.551% |
| Boryung Corporation | 189.8 Billion KRW | 55.416% |
| Bukwang Pharmaceutical Co., Ltd. | 56.83 Billion KRW | -48.902% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | -37.098% |
| JW Lifescience Corporation | 23.39 Billion KRW | -261.66% |